SCHEMBL30040229

SCHEMBL30040229

COc1cc(/C=C/C(=O)OC2O[C@H](CO[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](O)[C@H](O)[C@H]2OC(=O)/C=C/c2cc(OC)c(O)c(OC)c2)cc(OC)c1O

nearest known ligand 0.60

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ LDHA P00338 1/20 0.60
▸ EPHX2 P34913 7/20 0.57
▸ SNCA P37840 1/20 0.52
▸ ALDH1A1 P00352 1/20 0.49
▸ CYP3A4 P08684 1/20 0.49
▸ ALOX15 P16050 1/20 0.49
▸ MAPK1 P28482 1/20 0.49
▸ HSD17B10 Q99714 1/20 0.49
▸ PRKCA P17252 4/20 0.49
▸ PTGS1 P23219 2/20 0.48
▸ KDM1A O60341 1/20 0.47
▸ PTPN1 P18031 1/20 0.47
▸ CA12 O43570 2/20 0.46
▸ CA1 P00915 2/20 0.46
▸ CA2 P00918 2/20 0.46
▸ CA9 Q16790 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30040193 0.96 LDHA (0.57) LDHAEPHX2SNCAALDH1A1CYP3A4
SCHEMBL30039672 0.94 PRKCA (0.57) LDHAEPHX2SNCAALDH1A1CYP3A4
SCHEMBL30429113 0.92 LDHA (0.58) LDHAEPHX2SNCACYP3A4PRKCA
SCHEMBL2928116 0.92 LDHA (0.58) LDHAEPHX2SNCACYP3A4PRKCA
SCHEMBL26485996 0.92 LDHA (0.58) LDHAEPHX2SNCACYP3A4PRKCA
SCHEMBL30039394 0.90 PTPN1 (0.57) LDHAEPHX2SNCAALDH1A1CYP3A4
SCHEMBL546910 0.88 LDHA (0.65) LDHAEPHX2SNCACYP3A4PTGS1
SCHEMBL30192596 0.88 LDHA (0.65) LDHAEPHX2SNCACYP3A4PTGS1
SCHEMBL546911 0.88 LDHA (0.65) LDHAEPHX2SNCACYP3A4PTGS1
SCHEMBL15711524 0.88 LDHA (0.65) LDHAEPHX2SNCACYP3A4PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025049925-A2 LIPIDOID COMPOUNDS AND RELATED COMPOSITIONS AND USES POSEIDA THERAPEUTICS, INC. (US) 2025-03-06 — — WO disclosed
EP-4391834-A1 METHODS FOR IMPROVING GUT MICROBIOTA DIVERSITY Société des Produits Nestlé S.A. (CH) 2024-07-03 — — EP disclosed
WO-2023025722-A1 METHODS FOR IMPROVING GUT MICROBIOTA DIVERSITY Société des Produits Nestlé S.A. (CH) 2023-03-02 — — WO disclosed
EP-4085750-A1 LIGHT SOURCE FOR PLANT CULTIVATION Industry-University Cooperation Foundation of Chungbuk National University (KR) 2022-11-09 — — EP disclosed
Send feedback